Alzheimer's disease & dementia

Biogen reanalyzes studies, presses ahead on Alzheimer's drug

Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia.

Medications

Harms reporting in trials of orlistat

The reporting of trials of orlistat in the 1990s appears to have understated harms, both in the summarized results submitted to the European Medicines Agency for drug approval, and in the published papers, according to a ...

Health

FDA warns again about dangers of methanol-based hand sanitizers

(HealthDay)—The U.S. Food and Drug Administration is warning consumers not to use alcohol-based hand sanitizers containing methanol, or wood alcohol, which is used in fuel and antifreeze and is toxic if absorbed through ...

Medical research

FDA approves Phase II of stem cell trial for ALS

For nearly two years, University of Michigan neurologist Eva Feldman, M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral ...

Diseases, Conditions, Syndromes

FDA warns about treating COVID-19 with unproven drugs

(HealthDay)—Malaria drugs touted by some as potential "game changers" against COVID-19 are actually too dangerous for general use, the U.S. Food and Drug Administration warned Americans on Friday.

Medications

Lower-cost biotech drug gets thumbs up from FDA panel (Update)

The second-biggest selling drug in the world could get some cheaper competition in the U.S., after a federal panel endorsed an alternative version of the pricey medication used to treat rheumatoid arthritis and other inflammatory ...

page 14 from 24